We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current LSRM market cap is 46.36M. The company's latest EPS is USD -0.6848 and P/E is -1.45.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 536k | 559k | 0 | 0 | 0 |
| Operating Income | -20.12M | -28.98M | -36.19M | -36.06M | -31.48M |
| Net Income | -22.14M | -30.28M | -36.71M | -37.63M | -32.37M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.62M | 40.54M | 75.87M | 50.52M | 30.53M |
| Total Liabilities | 22.49M | 20.81M | 19.34M | 18.36M | 17.31M |
| Total Equity | 5.13M | 19.73M | 56.53M | 32.16M | 13.22M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -15.28M | -18.79M | -18.24M | -22.85M |
| Investing | N/A | -2.7M | -15.19M | 5.49M | -372k |
| Financing | N/A | 25.04M | 54.52M | -638k | 4.69M |
| Market Cap | 46.36M |
| Price to Earnings Ratio | -1.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.29 |
| Price to Book Ratio | 3.54 |
| Dividend Yield | - |
| Shares Outstanding | 47.26M |
| Average Volume (1 week) | 2.47k |
| Average Volume (1 Month) | 3.36k |
| 52 Week Change | -16.15% |
| 52 Week High | 2.90 |
| 52 Week Low | 0.9725 |
| Spread (Intraday) | 0.06 (5.69%) |
| Company Name | Cel-Sci Corp. |
| Address |
7700 e arapahoe rd centennial, colorado 80112 1268 |
| Website | https://www.cel-sci.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
